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ABSTRACT
Background: Although data from the Surveillance, Epidemiology, and End results (SEER)-affiliated cancer registry are
accessible to the public, there is a shortage of published research describing cancer incidences for White, Black, and other
residents in Georgia. The objective of this research is to provide an overview of the trends in incidence of cancer in Georgia.
Methods: Incidence data were obtained from the Surveillance, Epidemiology, and End Results (SEER) 9 program, supported
by the National Cancer Institute, spanning the years 1982 to 2011. To assess trends over time, age-adjusted cancer incidence
rates relative to the 2000 Standard US population and annual percent changes (APCs) were calculated using SEER*Stat
software.
Results: In Georgia, cancer incidence rates for women increased from 365.1 per 100,000 in 1982 to 404.2 per 100,000 in
2011, with an overall APC of 0.3% (95% confidence interval: 0.2 to 0.4), but, for men, cancer incidence rates showed a slight
decline from 528.0 per 100,000 in 1982 to 513.7 per 100,000 in 2011 (APC of 0.2%, 95% CI: -0.6 to 0.1). For Black, White,
and Other (Asian/Pacific Islanders/American Indians) females, there were increases in incidence in this period, with APC
values of 0.6, 0.4, and 0.3, respectively. For all males and for Black and White males, there were overall decreases in
incidence, with APC values of -0.2. For Other males, however, the APC value was -0.9.
Conclusions: In Georgia, increases in cancer incidence rates occurred during 1982-2011 among the female population and
within various racial groups in this population, but there was relative stability in incidence rates among the male population,
except for Other males.
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include approximately 10% of the US population based on
the 2010 census and cover nine different registries: Atlanta,
Georgia; San Francisco-Oakland, California; Connecticut;
Detroit, Michigan; Iowa; Hawaii; New Mexico; Utah; and
Seattle-Puget Sound, Washington. The SEER 9 data cover
more years (1973 through 2011) but have a smaller
geographic coverage relative to that in SEER 13 and SEER
18 data. The SEER 13 data cover approximately 13.4% of
the US population, including four additional areas (San
Jose-Monterey, Los Angeles, Alaska Natives, and Rural
Georgia) relative to the SEER 9 data. The SEER 18 data
include five more areas: Greater California, Kentucky,
Louisiana, New Jersey, and Greater Georgia. However, the
SEER 13 (1992-2011) and SEER 18 (2000-2011) data have
fewer years relative to the SEER 9 (1973-2011). In the
present effort, cancer incidence rates and 95% confidence
intervals (CIs) were calculated as cases per 100,000 persons
and age-adjusted to the 2000 US standard population using
SEER*Stat software (http://seer.cancer.gov/seerstat/). The
2000 US standard million population was used. This
research involved analyses of existing, publicly available
data and did not require review from any Institutional
Review Board.

INTRODUCTION
Although data from the Surveillance, Epidemiology, and
End results (SEER)-affiliated cancer registry are accessible
to the public, there is a shortage of published research
describing cancer incidences for White, Black, and other
residents in Georgia (Wagner et al. 2012). Trends in prostate
cancer incidence and mortality rates in Georgia have been
reported (Berman et al, 1993; Wagner et al, 2012; Welton
et al, 2015), but no literature has been published regarding
the trends in overall cancer incidence rates in this state. The
purpose of the present research was to investigate trends in
cancer rates in Georgia as reported in the SEER registry for
the period 1982–2011.
METHODS
Data
Incidence data are from the Surveillance, Epidemiology, and
End Results (SEER) 9 program, supported by the National
Cancer Institute, spanning the years 1982 to 2011. In
relation to cancer incidence, SEER has population-based
incidence data related to age, sex, race, and year of
diagnosis at geographic (county) levels. The SEER 9 areas
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1982 to 513.7 per 100,000 in 2011 (APC of 0.2%, 95% CI: 0.6 to 0.1). For men, the overall trends of cancer incidence
rates did not substantially increase or decrease. For both
female and male populations, nevertheless, data for the three
time-segment periods (1982 to 1991, 1992 to 2001, and
2002 to 2011) showed up-and-down trends.

Statistical Methods
Annual percent changes (APCs) were calculated by leastsquares linear regressions on the natural logarithm of the
annual age-adjusted rates to characterize trends in cancer
incidence rates over specified periods of time (by the tenyear periods of 1982-1991, 1992-2001, 2002-2011, and by a
thirty-year period, 1982-2011 (Kim et al. 2001). APCs and
corresponding 95% confidence intervals were calculated for
the overall populations, by gender, and by racial groups.

During the sub-segment period of 1982 through 1991, the
cancer incidence rates increased from 365.1 to 408.1, with
an APC of 1.0% (95% CI: 0.6 to 1.4) for the female
population and from 528.0 to 717.4 with an APC of 2.6%
(95% CI: 1.3 to 3.8) for the male population. In the timesegments of 1992-2001 and 2002-2011, cancer incidence
rates for males decreased, but rates for females tended to
increase and then to decline slightly during the most recent
ten-year period. For Black women, rates increased overall
with an APC of 0.6% (95% CI: 0.4 to 0.7); an APC of 0.2% for Black men was not statistically significant.
Similarly, rates for White women increased overall with an
APC of 0.4% (95% CI: 0.3 to 0.6); an APC of -0.2% for
White men was not statistically significant. The last time
segment (2002-2011) showed decreasing trends for both
genders and all races, with an APC of -1.2% for males (95%
CI:-2.0 to -0.3) but a statistically insignificant APC of -0.3%
for females (95% CI: -0.7 to 0.1).

Testing the hypothesis that the APC is equal to zero is
equivalent to testing the hypothesis that the slope of the line
in the regression is equal to zero. The statistical significance
in differences between two APCs was tested using
t-statistics with degree of freedom defined as the sum of the
number of years in both time periods minus four at 5% of
significance level. Statistical analyses were performed with
the use of SAS statistical software, version 9.3 (Statistical
Analysis Software Institute, Cary, NC) and R software
(version 3.2, www.r-project.org).
RESULTS
The trajectories of cancer incidence rates (cases/100,000)
were examined for Georgia and for the SEER9 areas. The
rates rose progressively until 2004 (416.4 in Georgia and
440.2 in SEER 9 areas), then showed a small decreasing
trend (Figure 1). Cancer incidence rates for Georgia were,
on average, lower by about 15/100,000 than those for SEER
9 areas. Figure 2 shows trajectories of cancer incidence rates
for females and males. For the entire period, the average
incidence rates were 390.2, 405.8, 573.7, and 554.8 for
females in Georgia, females in SEER9 areas, males in
Georgia, and males in SEER9 areas, respectively. After
1993, incidence rates for males in Georgia and SEER9 areas
showed decreasing trends. The SEER9 incidence rates for
males decreased steadily, but the rates for males in Georgia
had a slower decrease. For both Georgia and the SEER9
areas, the cancer incidence rates for females increased prior
to about 2000; after that time, the values remained steady.

DISCUSSION
Among the population in Atlanta, Georgia, and the SEER 9
areas, the cancer incidence increased until the mid-2000s,
but there was a small, steady decline in the incidence rates
afterwards. Gender-specific analyses show that trajectories
for males declined sharply after the early 1990s, then had a
small, steady decline after 2000. Race-specific analyses
indicated that White women and men had high incidences of
cancer, and the Other race group had a lower cancer
incidence relative to Whites and Blacks.
Monitoring cancer trends is a function of cancer
surveillance systems. Changes in the occurrence of cancer in
a population often lead to research on potential for changes
in cancer rates. Monitoring cancer trends allows evaluation
of the efficacy of cancer screening or detection methods
and, thereby, determination of priorities in cancer control
programs. Government officials and policy makers also use
information on cancer trends to allocate resources for cancer
research and prevention.

Trends in cancer incidence rates among race-specific subgroups were also investigated. SEER reports race-specific
cancer incidence in the categories White, Black, and Other.
The Other group includes Asian, Native American, and
Pacific Islanders. The White female group showed high
cancer incidence rates relative to Black and Other females
(Asian/Pacific Islanders/American Indians) (Figure 3). The
cancer incidence rates for the Other race group were low
relative to those for Whites and Blacks. In general, the
trajectories for cancer incidence increased until about 2004
and remained steady afterward.

The cancer incidence trends identified in this analysis likely
reflect societal influences. The flattening of the upward
incidence trajectory starting in the mid-1990s is likely the
result of the decrease in smoking rates that began in the
mid-1960s. The increased slope of the incidence curve for
men, but not women, beginning in the mid-1980s and
reversing in the early 1990s reflects the classic pattern that
follows the introduction of a new screening program -- in
this case, widespread screening for prostate cancer.

Absolute and relative changes in cancer incidence in
Georgia by sex and race for the years 1982, 1992, 2002, and
2011 were examined (Tables 1 and 2). During this period,
cancer incidence rates for women increased significantly
from 365.1 per 100,000 in 1982 to 404.2 per 100,000 in
2011, with an annual percent change (APC) of 0.3% (95%
confidence interval: 0.2 to 0.4). For the male population,
however, the cancer incidence rate in 2011 was similar to
that in 1982, with a slight decline from 519.6 per 100,000 in
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about 10% of the US population, and, for Georgia, the data
are limited to the Atlanta area and do not include rural areas.
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Table 1. Age-adjusted incidence rates for cancer in Georgia by sex and race
Cancer incidence
Age-adjusted rate per 100,000 individuals
1982
1992
2002
2011
All
365.1
408.1
412.3
404.2
Black
White
Other
All
Black
White
Other

306.0
384.6
160.6
528.0
596.4
513.4
354.9

392.8
418.4
224.9
717.4
803.3
703.0
321.0

397.4
430.8
246.9
600.8
674.1
595.2
259.2

395.2
431.1
215.8
513.7
562.9
513.5
256.6

Table 2. Annual percent change in cancer incidence rates in Georgia stratified by sex and race
Cancer incidence
Annual percent change (APC)
1982-1991
1992-2001
2002-2011
1982-2011
Female
All
1.0*
0.2
-0.3
0.3*
Black
2.4*
-0.4
-0.1
0.6*
White
0.8*
0.6*
-0.1
0.4*
Other
3.7
1.8
-0.7
0.3
Male
All
2.6*
-2.1*
-1.2*
-0.2
Black
2.1*
-1.9*
-1.7*
-0.2
White
2.7*
-2.1*
-1.0*
-0.2
Other
2.2
-1.9
-1.0
-0.9
* The APC is significantly different from zero (p-value is less than <0.05%)

The SEER 9 data are not independent of Hispanic ethnicity
because it does not contain information on Hispanic
ethnicity like the SEER 13 and SEER 18 databases. Thus, it
would be appropriate to compare the results with those from
SEER 13 and SEER 18 data. A non-statistically significant
decrease in cancer incidence rates among persons of the
Other race group may reflect an insufficient sample size,
leading to a lack of sufficient power. Even though the APCs
for the Other groups do not show statistical significance, the
trajectories show up-and-down trends during the individual
time periods.
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The risk of cancer can be influenced by a combination of
environmental, genetic, and behavioral factors. With the
Georgia Department of Public Health (GDPH), the Georgia
Cancer Control Consortium issued the second edition of
Georgia’s Comprehensive Cancer Control Plan (20142019), which focuses on reducing the risk of cancer
(Prevention), detecting cancer earlier (Detection), improving
diagnosis and treatment (Diagnosis and Treatment), and
enhancing survivorship. Survivorship can be increased
through advances in cancer diagnosis and treatment and by
building strong cancer prevention and control programs.
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Figure 1. Trajectory of incidence rates for cancer in Georgia and in SEER 9 areas. The Y-axis is incidence rates per
100,000, and the x-axis is year of diagnosis.

Figure 2. Trajectory of incidence rates for cancer by gender in Georgia and in SEER 9 areas. The Y-axis is
incidence rates per 100,000, and the x-axis is year of diagnosis.
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Figure 3. Trajectory of incidence rates for cancer by race in Georgia. The Y-axis is incidence rates per
100,000, and the x-axis is year of diagnosis.
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